Literature DB >> 23264145

Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.

Hang Yu1, Xiaomei Huang, Xiaosun Liu, Hailong Jin, Ge'er Zhang, Qing Zhang, Jiren Yu.   

Abstract

Immunosuppressive lymphocytes, such as regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs), play crucial roles in tumor escape. To investigate the roles of Tregs and pDCs in papillary thyroid cancer (PTC) plus multinodular non-toxic goiter (MNG), thyroid tissue and blood samples from 30 patients with PTC plus MNG and 30 MNG alone were analyzed for CD4(+) T cell, CD8(+) T cell, FoxP3(+) Treg, ICOS(+)FoxP3(+) Treg, and pDC numbers by immunohistochemistry (IHC), immunofluorescence, and flow cytometry. Plasma concentration of the cytokines interleukin 10 (IL-10) and transforming growth factor β (TGF-β) were measured by enzyme-linked immunosorbent assay as well. Both in thyroid tissue and peripheral blood, the numbers of Foxp3(+) Treg were significantly higher in patients with PTC plus MNG compared to patients with MNG alone; and as a prognostic marker, ICOS(+)Foxp3(+) Tregs represent a stronger predictor of disease progression than the total numbers of Foxp3(+) Tregs. Furthermore, a positive correlation between pDC and ICOS(+)Foxp3(+) Treg numbers in tissue of patients with PTC plus MNG was observed, suggesting that PTC-derived pDCs may induce the differentiation of naive CD4(+) T cells into ICOS(+)Foxp3(+)Tregs. This may be one of the mechanisms underlying tumor escape in PTC plus MNG patients. Our results suggest that Tregs and pDCs together contribute to the tumor escape in patients with PTC plus MNG.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264145     DOI: 10.1007/s12020-012-9853-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  41 in total

Review 1.  Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity.

Authors:  Y J Liu
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 2.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

4.  Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.

Authors:  S Schröder; W Schwarz; W Rehpenning; T Löning; W Böcker
Journal:  Am J Clin Pathol       Date:  1988-03       Impact factor: 2.493

5.  Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

Authors:  Nobuyoshi Hiraoka; Kaoru Onozato; Tomoo Kosuge; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

6.  Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen.

Authors:  Jurjen Tel; Annechien J A Lambeck; Luis J Cruz; Paul J Tacken; I Jolanda M de Vries; Carl G Figdor
Journal:  J Immunol       Date:  2010-03-19       Impact factor: 5.422

Review 7.  Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

Authors:  David H Munn; Andrew L Mellor
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

9.  Dendritic cell vaccination in medullary thyroid carcinoma.

Authors:  Anton Stift; Monika Sachet; Rubina Yagubian; Clemens Bittermann; Peter Dubsky; Christine Brostjan; Roswitha Pfragner; Bruno Niederle; Raimund Jakesz; Michael Gnant; Josef Friedl
Journal:  Clin Cancer Res       Date:  2004-05-01       Impact factor: 12.531

10.  Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter.

Authors:  M R Pelizzo; P Bernante; A Toniato; A Fassina
Journal:  Tumori       Date:  1997 May-Jun
View more
  29 in total

1.  Papillary thyroid carcinoma behavior: clues in the tumor microenvironment.

Authors:  Kensey Bergdorf; Donna C Ferguson; Mitra Mehrad; Kim Ely; Thomas Stricker; Vivian L Weiss
Journal:  Endocr Relat Cancer       Date:  2019-06       Impact factor: 5.678

2.  Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.

Authors:  Y Liu; X Yun; M Gao; Y Yu; X Li
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

3.  Association between FOXP3 gene polymorphisms and risk of differentiated thyroid cancer in Chinese Han population.

Authors:  Weichao Jiang; Lei Zheng; Lijuan Xu; Yang Zhang; Xingxin Liu; Lihua Hu; Xiaobei Wang
Journal:  J Clin Lab Anal       Date:  2016-11-28       Impact factor: 2.352

Review 4.  The immune network in thyroid cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

5.  Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?

Authors:  Alev Selek; Berrin Cetinarslan; Ilhan Tarkun; Zeynep Canturk; Berna Ustuner; Zeynep Akyay
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-08       Impact factor: 2.503

6.  Expression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma.

Authors:  Qiang Liu; Mulati Rexiati; Ying Yang; Wen-Guang Wang; Baihetiya Azhati; Weilijiang Saimaiti; Yu-Jie Wang
Journal:  Med Oncol       Date:  2014-02-20       Impact factor: 3.064

7.  Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas.

Authors:  Ju-Yeon Kim; Taejin Park; Sang-Ho Jeong; Chi-Young Jeong; Young-Tae Ju; Young-Joon Lee; Soon-Chan Hong; Woo-Song Ha; Sang-Kyung Choi; Eun Jung Jung
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

8.  Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.

Authors:  Mahua Dey; Alan L Chang; Jason Miska; Derek A Wainwright; Atique U Ahmed; Irina V Balyasnikova; Peter Pytel; Yu Han; Alex Tobias; Lingjiao Zhang; Jian Qiao; Maciej S Lesniak
Journal:  J Immunol       Date:  2015-05-29       Impact factor: 5.422

Review 9.  Immune Landscape of Thyroid Cancers: New Insights.

Authors:  Elisa Menicali; Martina Guzzetti; Silvia Morelli; Sonia Moretti; Efisio Puxeddu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-27       Impact factor: 5.555

Review 10.  The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy.

Authors:  Amandeep Singh; Jeehoon Ham; Joseph William Po; Navin Niles; Tara Roberts; Cheok Soon Lee
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.